The state of New Jersey currently has 2 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
HEALEY ALS Platform Trial - Master Protocol
Recruiting
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Amyotrophic Lateral Sclerosis
RAPA-501 Therapy for ALS
Recruiting
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Gender:
All
Ages:
18 years and above
Trial Updated:
08/25/2023
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Amyotrophic Lateral Sclerosis